Streetbeat News

Analyst Ratings

XRAY

Dentsply Sirona reported Q2 earnings of $0.51 per share, beating the analyst consensus estimate of $0.43 by 18.6%. The company's quarterly sales were $1.03 billion, surpassing the analyst consensus estimate of $992.15 million by 3.61%. However, this represents a 26.09% decrease in earnings and a 0.49% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:29 pm

OM

Outset Medical reported Q2 earnings per share (EPS) of $(0.69), beating the analyst consensus estimate of $(0.73) by 5.48%. This is a 10.39% increase over losses from the same period last year. The company also reported quarterly sales of $36.00 million, beating the analyst consensus estimate of $35.18 million by 2.33%. This is a 43.67% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:26 pm

KRO

Kronos Worldwide (NYSE:KRO) reported Q2 losses of $(0.07) per share, missing the analyst consensus estimate of $0.03 by 333.33%. The company's quarterly sales were $443.20 million, missing the analyst consensus estimate of $480.27 million by 7.72%. This represents a 117.5% decrease in earnings and a 21.60% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:25 pm

ACAD

ACADIA Pharmaceuticals reported Q2 earnings of $0.01 per share, beating the analyst consensus estimate of $(0.08) by 112.5%. The company also reported quarterly sales of $165.24 million, beating the analyst consensus estimate of $157.81 million by 4.71%. This represents a 104.76% increase in earnings and a 22.79% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:23 pm

KN

Knowles Corporation (NYSE:KN) reported Q2 earnings of $0.23 per share, beating the analyst consensus estimate of $0.22 by 4.55%. However, this is a 30.3% decrease from the same period last year. The company also reported quarterly sales of $173.00 million, beating the estimate of $172.32 million by 0.39%, but this is a 7.98% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:23 pm

UTRS

Minerva Surgical reported Q2 earnings per share (EPS) of $(0.05), beating the analyst consensus estimate of $(0.09) by 44.44%. However, the company's quarterly sales of $13.40 million missed the analyst consensus estimate of $13.92 million by 3.74%. This represents a 75% increase in EPS and a 3.34% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:22 pm

CPSS

Consumer Pf Servs (NASDAQ:CPSS) reported Q2 earnings of $0.55 per share, a decrease of 39.56% YoY. However, the company's quarterly sales of $84.86 million beat the analyst consensus estimate of $76.31 million by 11.20%, marking a 3.46% increase over sales from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 04, 2023 | 12:21 pm

ZIMV

ZimVie (NASDAQ:ZIMV) reported Q2 earnings of $0.17 per share, beating the analyst consensus estimate of $0.02 by 750 percent. However, this is a 74.63 percent decrease from the same period last year. The company also reported quarterly sales of $224.90 million, beating the analyst consensus estimate of $211.00 million by 6.59 percent, but this is a 4.12 percent decrease from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 04, 2023 | 12:21 pm

DLTR

In the last quarter, 18 analysts have provided ratings for Dollar Tree (NASDAQ:DLTR), with 12 being bullish or somewhat bullish, and 6 being indifferent. The company has an average 12-month price target of $156.11, a decrease of 3.38% from the previous average price target of $161.57.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 12:21 pm

NWPX

Northwest Pipe (NASDAQ:NWPX) reported Q2 earnings of $0.74 per share, missing the analyst consensus estimate of $0.79 by 6.33%. This is a 28.85% decrease from the same period last year. However, the company's quarterly sales of $116.37 million beat the analyst consensus estimate of $113.12 million by 2.87%, despite being a 1.81% decrease from last year.

Portfolio Pulse from vinayak@benzinga.com

August 04, 2023 | 12:21 pm